Добірка наукової літератури з теми "Fighting antibiotic resistance"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Fighting antibiotic resistance".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Fighting antibiotic resistance"

1

Goldhaber, M. "Fighting antibiotic resistance." Science 266, no. 5190 (December 2, 1994): 1462. http://dx.doi.org/10.1126/science.7985006.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Voelker, R. "Fighting Antibiotic Resistance." JAMA: The Journal of the American Medical Association 283, no. 4 (January 26, 2000): 470—b—470. http://dx.doi.org/10.1001/jama.283.4.470-b.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Voelker, Rebecca. "Fighting Antibiotic Resistance." JAMA 283, no. 4 (January 26, 2000): 470. http://dx.doi.org/10.1001/jama.283.4.470-jqu90012-3-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Brouillette, Monique. "Fighting Antibiotic Resistance with Biology." Inside Precision Medicine 9, no. 4 (August 1, 2022): 18–20. http://dx.doi.org/10.1089/ipm.09.04.05.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Tacconelli, Evelina, and Giulia De Angelis. "Fighting antibiotic resistance all over Europe." Expert Review of Anti-infective Therapy 8, no. 7 (July 2010): 761–63. http://dx.doi.org/10.1586/eri.10.57.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Levy, Stuart B. "Fighting the Specter of Antibiotic Resistance." Infectious Diseases in Clinical Practice 7, no. 6 (August 1998): 261–64. http://dx.doi.org/10.1097/00019048-199808000-00006.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Plantinga, Nienke L., Bastiaan HJ Wittekamp, Pleun J. van Duijn, and Marc JM Bonten. "Fighting antibiotic resistance in the intensive care unit using antibiotics." Future Microbiology 10, no. 3 (March 2015): 391–406. http://dx.doi.org/10.2217/fmb.14.146.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Huang, Yuanling, Wenhui Wang, Zhihao Zhang, Yufeng Gu, Anxiong Huang, Junhao Wang, and Haihong Hao. "Phage Products for Fighting Antimicrobial Resistance." Microorganisms 10, no. 7 (June 30, 2022): 1324. http://dx.doi.org/10.3390/microorganisms10071324.

Повний текст джерела
Анотація:
Antimicrobial resistance (AMR) has become a global public health issue and antibiotic agents have lagged behind the rise in bacterial resistance. We are searching for a new method to combat AMR and phages are viruses that can effectively fight bacterial infections, which have renewed interest as antibiotic alternatives with their specificity. Large phage products have been produced in recent years to fight AMR. Using the “one health” approach, this review summarizes the phage products used in plant, food, animal, and human health. In addition, the advantages and disadvantages and future perspectives for the development of phage therapy as an antibiotic alternative to combat AMR are also discussed in this review.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Mehrabi, Mohammad Reza, Madjid Soltani, Mohsen Chiani, Kaamran Raahemifar, and Ali Farhangi. "Nanomedicine: New Frontiers in Fighting Microbial Infections." Nanomaterials 13, no. 3 (January 25, 2023): 483. http://dx.doi.org/10.3390/nano13030483.

Повний текст джерела
Анотація:
Microbes have dominated life on Earth for the past two billion years, despite facing a variety of obstacles. In the 20th century, antibiotics and immunizations brought about these changes. Since then, microorganisms have acquired resistance, and various infectious diseases have been able to avoid being treated with traditionally developed vaccines. Antibiotic resistance and pathogenicity have surpassed antibiotic discovery in terms of importance over the course of the past few decades. These shifts have resulted in tremendous economic and health repercussions across the board for all socioeconomic levels; thus, we require ground-breaking innovations to effectively manage microbial infections and to provide long-term solutions. The pharmaceutical and biotechnology sectors have been radically altered as a result of nanomedicine, and this trend is now spreading to the antibacterial research community. Here, we examine the role that nanomedicine plays in the prevention of microbial infections, including topics such as diagnosis, antimicrobial therapy, pharmaceutical administration, and immunizations, as well as the opportunities and challenges that lie ahead.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Antwi, AN, A. Stewart, and Michelle Crosbie. "Fighting antibiotic resistance: a narrative review of public knowledge, attitudes, and perceptions of antibiotics use." Perspectives in Public Health 140, no. 6 (June 9, 2020): 338–50. http://dx.doi.org/10.1177/1757913920921209.

Повний текст джерела
Анотація:
Aims: The aims of this study were to ascertain the comprehensive knowledge, perceptions, and attitudes of people from varying socioeconomic regions towards antibiotic use; identify the misperceptions and malpractices; and inform health policy and practice. Method: EBSCO host databases, PubMed, and Google Scholar were searched to obtain relevant primary research papers within the years 2010–2018. Search phrases included the following: ‘antibiotics use’, ‘community perceptions’, ‘public opinion, knowledge, behaviour, practices, perceptions’. Initially, selected papers were screened using the Preview, Question, Read, Summarize (PQRS) model. Results: Review of the 20 articles selected was based on six identified themes. It was found that insufficient knowledge and awareness of antibiotics use; self-medication and the use of leftover antibiotics; treating viral diseases with antibiotics or used as painkillers; expecting antibiotic prescription as a culmination of consultation; and the credibility of information obtained are issues that cut across different countries. Conclusion: Evidence from this review suggests that misconceptions of antibiotic use are similar in different countries. Therefore, the need for the development and implementation of transferable policies as well as educating the public is necessary for the fight against ABR.
Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "Fighting antibiotic resistance"

1

Cremonini, Eleonora. "ANTIMICROBIAL AND ANTIBIOFILM ACTIVITIES OF BIOGENIC SELENIUM NANOPARTICLES: A CONTRIBUTION TO THE DEVELOPMENT OF AN ALTERNATIVE STRATEGY AGAINST THE ANTIBIOTIC RESISTANCE CONCERN." Doctoral thesis, 2018. http://hdl.handle.net/11562/985378.

Повний текст джерела
Анотація:
Bacterial biofilms are microbial communities embedded in a highly hydrated exopolymer (EPS) matrix and can exist on different biotic and abiotic surfaces. The presence of these protective EPS matrix allows biofilms to survive in harsh environmental conditions and to resist to antiobiotic action, representing a challenge for the common antimicrobial therapy. Recently, a wide range of nanoparticles (i.e. silver, gold, iron oxide) have been intensively studied as antimicrobial agents including their use against multidrug-resistant (MDR) bacteria. In the present study the physiochemical characteristics of biogenically produced Selenium Nanoparticles were evaluated along with their antimicrobial and antibiofilm activity.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

PERRIN, ELENA. "Fighting Burkholderia cepacia complex: exploring virulence, new antimicrobials and antibiotics resistance." Doctoral thesis, 2014. http://hdl.handle.net/2158/847694.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Fighting antibiotic resistance"

1

Gould, Ian M., and Jos WM van der Meer, eds. Antibiotic Policies: Fighting Resistance. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

(Editor), Ian M. Gould, and Jos W.M. van der Meer (Editor), eds. Antibiotic Policies: Fighting Resistance. Springer, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gould, Ian M., and Jos W. M. van der Meer. Antibiotic Policies: Fighting Resistance. Springer, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Antibiotic Policies: Fighting Resistance. Springer, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Institutional infection control: Practical strategies for fighting antibiotic resistance. Toronto: Insight Press, 1998.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Bagnoli, Fabio, Sanjay Kumar Phogat, Isabelle Bekeredjian-Ding, and Rachel McLoughlin, eds. Fighting an Elusive Enemy: Staphylococcus aureus and its Antibiotic Resistance, Immune-Evasion and Toxic Mechanisms. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-266-0.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

The Antibiotic Alternative: The Natural Guide to Fighting Infection and Maintaining a Healthy Immune System. Healing Arts Press, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Natural Antibiotics and Antivirals: 18 Infection-Fighting Herbs and Essential Oils. Inner Traditions International, Limited, 2018.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Vasey, Christopher. Natural Antibiotics and Antivirals: 18 Infection-Fighting Herbs and Essential Oils. Inner Traditions International, Limited, 2018.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Fighting antibiotic resistance"

1

Dancer, Stephanie J. "Consequences of Antimicrobial Chemotherapy: Overgrowth, Resistance, and Virulence." In Antibiotic Policies: Fighting Resistance, 1–15. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Ciofu, Oana, and Niels Høiby. "Cystic Fibrosis—Coping with Resistance." In Antibiotic Policies: Fighting Resistance, 149–74. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Bonten, Marc J. M., and Jan Jelrik Oosterheert. "Community-Acquired Pneumonia—Back to Basics." In Antibiotic Policies: Fighting Resistance, 175–91. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Torres, Marìa V., Patricia Mu≁oz, and Emilio Bouza. "Hospital-Acquired Pneumonia: Diagnostic and Treatment Options." In Antibiotic Policies: Fighting Resistance, 193–207. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Gould, Ian M. "Optimizing Antimicrobial Chemotherapy in the ICU—A Review." In Antibiotic Policies: Fighting Resistance, 209–22. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_13.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Tacconelli, Evelind. "Risk Assessment for Methicillin-Resistant Staphylococcus aureus." In Antibiotic Policies: Fighting Resistance, 223–36. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zanetti, Giorgio. "What Do We Do with Methicillin-Resistant Staphylococcus aureus in Surgery?" In Antibiotic Policies: Fighting Resistance, 237–51. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Kluytmans, Jan A. J. W., and Bram M. W. Diederen. "Control of Healthcare-Associated Methicillin-ResistantStaphylococcus aureus." In Antibiotic Policies: Fighting Resistance, 253–69. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_16.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

van der Meer, Jos W. M., and Richard P. T. M. Grol. "The Process of Antibiotic Prescribing: Can It Be Changed?" In Antibiotic Policies: Fighting Resistance, 17–27. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Harbarth, Stephan, and Dominique L. Monnet. "Cultural and Socioeconomic Determinants of Antibiotic Use." In Antibiotic Policies: Fighting Resistance, 29–40. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-70841-6_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Fighting antibiotic resistance"

1

AlBERMANI, Oruba K., Isrra Adnan Auda KHADHIM, and Nebras Mohammed SAHI. "ANTIMICROBIAL SUSCEPTIBILITY PATTERN AND THE ANTAGONISTIC EFFECT OF LACTOBACILLUS IN FIGHTING SHIGELLA SPP. ISOLATED FROM DIARRHEIC CHILDREN." In III.International Scientific Congress of Pure,Appliedand Technological Sciences. Rimar Academy, 2021. http://dx.doi.org/10.47832/minarcongress3-9.

Повний текст джерела
Анотація:
Background: Shigella is an major source of bacterial gastroenteritis in lack of health awareness in society. The handling of shigellos is mostly requires antibiotics. The using of probiotic of Lactic acid bacteria possess the counter effect against many dangerous bacterial pathogens which associated with gastroenteritis like Shigella spp. Aim: the purpose of this study to estimate the influence of lactic bacteria of the genus Lactobacillus on the population Shigella as a main pathogen involved in gastroenteritis in children. Patients and methods: A total of 50 stool specimens were collected during the period September2019 to January 2020 from diarrheic children patients age range(1-3)years. Standard bacteriological methods were used to isolate, identify, and determine the antimicrobial susceptibility pattern of Shigellaisolates, and we used fresh culture of Lactobacillus 24 h (previously isolated as member of fecal microbiota from healthy person and identified by molecular assay). Then we done centrifugation to obtain supernatant which have test bioactive materials like bacteriocin. These bacteriocin materials subjected to own antibacterial activity against other bacterial pathogen like Shigella spp. By using agar diffusion method . Results: All the 14 Shigella spp. isolates show 100% resistance to nalidixic acid,. cotrimoxazole , and High resistance to ciprofloxacin (85%), and moderate resistant of ampicillin (64%). In agar- well diffusion method indicated the high antagonistic activity of the strains of Lactobacillus 2, 3, and 4 isolated from health GI tract against all Shigella spp., as a result of their activity the total elimination of Shigella within 24 h was observed. conclusion: the Shigella spp. Strains exhibited antibiotic resistant against more one type of antiobiotic The lactobacilii strains tested during this study showed strong antimicrobial activity against Shigella spp. Key words: Shigellos is, Lactobacillus, 16S Rrna.
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії